Quantifying excess TB prevalence among people living with HIV on ART in the universal ART era: Evidence from a TB prevalence survey in Zambia and South Africa

Despite widespread antiretroviral therapy (ART) scale-up, tuberculosis (TB) remains a leading cause of morbidity and mortality among people living with HIV (PLHIV). While ART reduces TB incidence among PLHIV, its effect on TB prevalence remains less clear. We estimated the difference in TB prevalen